Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

10

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

10 companies

Chugai Pharmaceutical

Market Cap: JP¥11.8t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,185.00

7D

6.2%

1Y

17.2%

Otsuka Holdings

Market Cap: JP¥6.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥12,395.00

7D

1.8%

1Y

57.8%

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan and internationally.

4568

JP¥2,779.50

7D

4.5%

1Y

-22.2%

Astellas Pharma

Market Cap: JP¥4.2t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,327.50

7D

1.7%

1Y

40.9%

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥2,822.50

7D

-0.1%

1Y

7.0%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,602.50

7D

3.5%

1Y

-1.0%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,434.50

7D

4.1%

1Y

41.0%

Santen Pharmaceutical

Market Cap: JP¥632.6b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥1,961.50

7D

4.6%

1Y

27.3%

Tsumura

Market Cap: JP¥281.6b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥3,746.00

7D

-0.5%

1Y

5.0%

Nippon Shinyaku

Market Cap: JP¥242.8b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥3,603.00

7D

1.8%

1Y

10.3%